Annual EPS
Summary
- Current Value
- As of today, MRNA annual EPS is -$7.25, up +21.77% on
- Historical Performance
- MRNA annual EPS is down -136.09% over the past 3 years, down -270.30% over the past 5 years
- All-Time High Comparison
- MRNA annual EPS is currently -101.13% below its historical high of $640.00 set on
- 3-Year Low Comparison
- MRNA annual EPS is +41.21% above its 3-year low of -$12.34 reached on
- Sector Comparison
- MRNA annual EPS is higher than 14.06% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate MRNA annual EPS at -$8.80, -21.33% lower than the current value
- Upcoming Earnings
- As of today, the next annual earnings release for MRNA has not been scheduled
EPS Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | -$7.25 | +21.8% | -136.1% | -270.3% | +99.8% | |
| Quarterly EPS | $0.00 | +100.0% | -100.0% | -100.0% | +100.0% | |
| TTM EPS | -$4.75 | +45.6% | -141.0% | -478.5% | +99.8% | |
| Price | $47.30 | +71.3% | -64.8% | -72.8% | – | |
| Annual Revenue | $1.94B | -39.9% | -89.8% | +142.0% | +10000.0% | |
| PE Ratio | - | – | – | – | – | |
| Annual Net Income | -$2.82B | +20.8% | -133.8% | -277.8% | -10000.0% | |
| Annual Gross Profit | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Shares Outstanding | 396.59M | +2.5% | +4.0% | -1.2% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $20.10 | N/A | -136.1% |
| 5Y | $28.31 | -125.6% | |
| All | $640.00 | -101.1% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$12.34 | +41.2% | |
| 5Y | -$12.34 | +41.2% | |
| All | -$17.68K | +100.0% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$9.15 | -$9.27 | -1.30% | |
| -$7.89 | -$7.25 | +8.04% | |
| -$8.80 | N/A | -21.33% | |
| -$4.66 | N/A | +35.81% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
What is the current annual EPS of MRNA?
As of today, MRNA annual EPS is -$7.25
What is 1-year change in MRNA annual EPS?
MRNA annual EPS is up +21.77% year-over-year
What is 3-year change in MRNA annual EPS?
MRNA annual EPS is down -136.09% over the past 3 years
How far is MRNA annual EPS from its all-time high?
MRNA annual EPS is currently -101.13% below its historical high of $640.00 set on June 1, 1994
How does MRNA annual EPS rank versus sector peers?
MRNA annual EPS is higher than 14.06% of companies in Healthcare sector
How does the analyst estimate for MRNA annual EPS compare to its current value?
Analysts estimate MRNA annual EPS at -$8.80, -21.33% lower than the current value
When is MRNA next annual earnings release?
As of today, the next annual earnings release for MRNA has not been scheduled
Quarterly EPS
Summary
- Current Value
- As of today, MRNA quarterly EPS is $0.00, up +100.00% on
- Historical Performance
- MRNA quarterly EPS is up +100.00% year-over-year, down -100.00% over the past 3 years
- All-Time High Comparison
- MRNA quarterly EPS is currently -100.00% below its historical high of $9,600.00 set on
- 3-Year Low Comparison
- MRNA quarterly EPS is +100.00% above its 3-year low of -$9.53 reached on
- Sector Comparison
- MRNA quarterly EPS is higher than 75.42% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for MRNA is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $0.00 | +100.0% | +100.0% | -100.0% | -100.0% | |
| Annual EPS | -$7.25 | – | +21.8% | -136.1% | -270.3% | |
| TTM EPS | -$4.75 | +34.6% | +45.6% | -141.0% | -478.5% | |
| Price | $47.30 | +10.6% | +71.3% | -64.8% | -72.8% | |
| Quarterly Revenue | $389.00M | -42.6% | +260.2% | -79.2% | -79.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Net Income | -$1.34B | -62.6% | -38.3% | -1800.0% | -210.0% | |
| Quarterly Gross Profit | $0.00 | -100.0% | +100.0% | -100.0% | -100.0% | |
| Shares Outstanding | 396.59M | – | +2.5% | +4.0% | -1.2% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.55 | -100.0% | |
| 5Y | $11.29 | -100.0% | |
| All | $9,600.00 | -100.0% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$2.52 | N/A | +100.0% |
| 3Y | -$9.53 | +100.0% | |
| 5Y | -$9.53 | +100.0% | |
| All | -$6,720.00 | +100.0% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.60 | -$2.11 | +18.99% | |
| -$3.06 | $0.00 | +100.00% | |
| -$2.15 | N/A | - | |
| -$1.05 | N/A | - |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
What is the current quarterly EPS of MRNA?
As of today, MRNA quarterly EPS is $0.00
What is MRNA quarterly EPS most recent change?
MRNA quarterly EPS was up +100.00% on March 31, 2026
What is 1-year change in MRNA quarterly EPS?
MRNA quarterly EPS is up +100.00% year-over-year
How far is MRNA quarterly EPS from its all-time high?
MRNA quarterly EPS is currently -100.00% below its historical high of $9,600.00 set on June 1, 2003
How does MRNA quarterly EPS rank versus sector peers?
MRNA quarterly EPS is higher than 75.42% of companies in Healthcare sector
When is MRNA next earnings release?
The next earnings release for MRNA is on
TTM EPS
Summary
- Current Value
- As of today, MRNA TTM EPS is -$4.75, up +34.64% on
- Historical Performance
- MRNA TTM EPS is up +45.59% year-over-year, down -140.96% over the past 3 years
- All-Time High Comparison
- MRNA TTM EPS is currently -100.49% below its historical high of $977.07 set on
- 3-Year Low Comparison
- MRNA TTM EPS is +69.72% above its 3-year low of -$15.68 reached on
- Sector Comparison
- MRNA TTM EPS is higher than 17.25% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate MRNA TTM EPS at -$4.77, -0.51% lower than the current value
- Upcoming Earnings
- The next earnings release for MRNA is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | -$4.75 | +34.6% | +45.6% | -141.0% | -478.5% | |
| Quarterly EPS | $0.00 | +100.0% | +100.0% | -100.0% | -100.0% | |
| Annual EPS | -$7.25 | – | +21.8% | -136.1% | -270.3% | |
| Price | $47.30 | +10.6% | +71.3% | -64.8% | -72.8% | |
| TTM Revenue | $2.23B | +14.4% | -30.0% | -85.1% | -18.6% | |
| PE Ratio | - | – | – | – | – | |
| TTM Net Income | -$3.19B | -13.2% | +4.9% | -166.8% | -634.0% | |
| TTM Gross Profit | $882.00M | +2.4% | -42.2% | -90.6% | -64.6% | |
| Shares Outstanding | 396.59M | – | +2.5% | +4.0% | -1.2% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$4.75 | at high | |
| 3Y | $11.59 | N/A | -141.0% |
| 5Y | $34.01 | -114.0% | |
| All | $977.07 | -100.5% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$8.72 | N/A | +45.6% |
| 3Y | -$15.68 | +69.7% | |
| 5Y | -$15.68 | +69.7% | |
| All | -$19.20K | +100.0% |
TTM EPS History
FAQ
What is the current TTM EPS of MRNA?
As of today, MRNA TTM EPS is -$4.75
What is MRNA TTM EPS most recent change?
MRNA TTM EPS was up +34.64% on March 31, 2026
What is 1-year change in MRNA TTM EPS?
MRNA TTM EPS is up +45.59% year-over-year
How far is MRNA TTM EPS from its all-time high?
MRNA TTM EPS is currently -100.49% below its historical high of $977.07 set on June 1, 1994
How does MRNA TTM EPS rank versus sector peers?
MRNA TTM EPS is higher than 17.25% of companies in Healthcare sector
How does the analyst estimate for MRNA TTM EPS compare to its current value?
Analysts estimate MRNA TTM EPS at -$4.77, -0.51% lower than the current value
When is MRNA next earnings release?
The next earnings release for MRNA is on
EPS Formula
Data Sources & References
- MRNA Official Website www.modernatx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000162828025053816/0001628280-25-053816-index.htm
- MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
- MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna
